CME Group Inc (CME)

CME Group Inc. is a financial markets company that operates contract markets for futures and options on futures trading around the world. Through its exchanges and related businesses, the company lists products tied to interest rates, equity indexes, foreign exchange, agricultural commodities, energy, metals, fixed income, and foreign currency. CME Group also provides clearing house services for futures, options, and cleared swap transactions, including clearing, settlement, and contract guarantee functions. In addition, it supplies market data services, including real-time and historical information, to a broad client base that includes professional traders, financial institutions, corporations, investors, manufacturers, producers, governments, and central banks. The company, formerly known as Chicago Mercantile Exchange Holdings Inc., adopted its current name in July 2007 and is headquartered in Chicago, Illinois.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-CME
$269.25
11.8% Upside
Fair
$280.13
16.3% Upside
Fair
Good
5.2
2.1%
July 22, 2026
20.5x
3.3x
12.9x
88.818 B
88.36 B
4.0%
98.6%
0.5
95.2%
102.0%
Valuation • Fair Value

CME Group Inc (NASDAQ-CME) Fair Value by Valuation Model

Compare the primary fair value estimate for CME Group Inc (NASDAQ-CME) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$269.25

Estimated upside of 11.8% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$270.38

Discounted cash flow valuation reference.

Ben Graham Formula Value

$129.98

Classic Ben Graham valuation formula reference.

DDM Fair Value

$382.65

Dividend discount model valuation reference.

EPV Fair Value

$122.66

Earnings power value estimate.

Comps Fair Value

$254.75

Comparable-company valuation reference.

Analyst Price Target

$280.13

Analysts imply upside of 16.3%.

How to read these valuation models

Use this section to compare the primary fair value estimate for CME Group Inc (NASDAQ-CME) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for CME Group Inc (NASDAQ-CME)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

6.744 B

Current operating scale indicator.

Revenue Forecast

6.993 B

Forward revenue estimate.

EBITDA

4.793 B

Current operating profitability reference.

EBITDA Forecast

4.955 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review CME Group Inc (NASDAQ-CME) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for CME Group Inc (NASDAQ-CME)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.43

No elevated caution signal from this screen.

Altman Z-Score

0.5

Lower score that deserves closer risk review.

FCF / Net Income

102.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for CME Group Inc (NASDAQ-CME). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for CME Group Inc (NASDAQ-CME)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 22, 2026

Days to Earnings

1

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

2.1%

Income yield reference.

Upcoming Dividend

5.2

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

95.2%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for CME Group Inc (NASDAQ-CME), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

CME Group Inc (NASDAQ-CME) Stock Forecast & Technical Outlook

Review CME Group Inc (NASDAQ-CME) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for CME Group Inc (NASDAQ-CME) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for CME Group Inc (NASDAQ-CME) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for CME Group Inc (NASDAQ-CME) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for CME Group Inc (NASDAQ-CME) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for CME Group Inc (NASDAQ-CME) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for CME Group Inc (NASDAQ-CME)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, CME Group Inc (NASDAQ-CME) has a Hold consensus, with 4 buy, 4 hold and 1 sell recommendations in the current data set.

Buy 4
Hold 4
Sell 1
FAQ Fast Investor Answers

CME Group Inc (NASDAQ-CME) Stock FAQ

Quick answers about CME Group Inc (NASDAQ-CME) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$269.25
Estimated upside 11.8%
Valuation Rating
Undervalued
Estimated upside of 11.8%
Analyst Target
$280.13
Implied upside 16.3%
Financial Health
Good
Current financial-health read

The current fair value estimate for CME Group Inc (NASDAQ-CME) is $269.25. This implies an estimated upside of 11.8% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 11.8% versus the current market price.

The available analyst price target for CME Group Inc (NASDAQ-CME) is $280.13. The analyst target implies estimated upside of 16.3%.

The current financial health read for CME Group Inc (NASDAQ-CME) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for CME Group Inc (NASDAQ-CME) is July 22, 2026.

Based on the current data, dividend yield is 2.1%, upcoming dividend amount is 5.2.

The current P/E ratio listed for CME Group Inc (NASDAQ-CME) is 20.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for CME Group Inc is 88.818 B.

The current enterprise value listed for CME Group Inc is 88.36 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for CME Group Inc is NASDAQ-CME, and the stock is listed on NASDAQ.

CME Group Inc (NASDAQ-CME) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for CME Group Inc is 4.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for CME Group Inc is 98.6%. Free float helps investors understand how much of the share base is available for public trading.